维普中文期刊产品整合服务
21篇 您的检索式:作者名="Kyulo NL"
    题名 作者 年代 出处 被引量
1Octrcotide midodrine therapy significantly improves renal function and 30-day survivalin patients with typehepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 0,,03:1
2Octreotide Midodrine therapy significantly improves renal function and 30 - day survival in patients with type 1 hepatorenal syndrome 显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
3Clinical significance of elevated alpha -fetoprotein(AFP) in patients with chronic hepatitis C,but not hepa- tocellular carcinoma显示文摘Hu KQ Kyulo NL Lim N 2004Am J Gastroenterol2004,99,:1
4Overweight and obesity,hepatic steatosis, and progression of chronic hepatitis C: A retrospective study on a large cohorl of patients in the United States 显示文摘Hu KQ Kyulo NL Esrailian ET 2004J Hepatol2004,,:1
5Octreotide/Midodrine, therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Digestive Diseases And Sciences2007,52,3:1
6Clinical significance of elevat- ed alpha-fetoprotein (AFP) in patients with chronic hepatitis C but not hepatoeellular carcinoma 显示文摘Hu KQ Kyulo NL Lim N 2004Am J Gastroenterol2004,99,5:1
7Octreotide/Midodrine, therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Digestive Diseases And Sciences2007,52,3:1
8Clinical significance of elevated alpha-fetoprotein (AFP) in patlcnts with chronic hepatitis C ,but not hepatocellular carcinoma显示文摘Hu KQ Kyulo NL 2004Am J Gastroentero12004,99,:1
9Clinical significance of ele-vated alpha-fetoprotein(AFP)in patients with chronic hepatitis C,but not hepatocellular carcinoma显示文摘Hu KQ Kyulo NL Lim N Am J G0,,:1
10Oetrrotide/ midodrine therapy significantly improves renal function and 30 day survival in patients with type 1 hepatorenal syndrome 显示文摘ESRAILIAN E PANTANGCO ER KYULO NL 2007Dig Dis Sci2007,52,:1
11MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis 显示文摘Srikureja W Kyulo NL Runyon BA 2005Journal of Hepatology2005,42,5:1
12Oetreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome 显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
13Octreotide/Midodrine therapy significantly improves renal function and 30- day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
14Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma 显示文摘Hu KQ Kyulo NL 2004Am J Gastroenterol2004,99,5:1
15Clinical significance of elevated alpha-fetoprotein(AFP)in patients with chronic hepatitis C,but not hepatocellular carcinoma显示文摘Hu KQ Kyulo NL Lim N 0,,:1
16MELD score is a better prognostic model than Child-Turcotte-Pugh score or Diseriminanl Function score in patients with alcoholic hepatitis显示文摘Srikureja W Kyulo NL Runyon BA et ol 2005J Hepatol2005,42,5:1
17Octreotidel Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
18Clinical significance of elevated alpha- fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocel- lular careinoma显示文摘Hu KQ Kyulo NL Lim N 2004Am J Gastroenteml2004,99,5:1
19Octreotide/Midodrine therapy si gnificantly improves renal function and 30-day survival in patients with type 1hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Digestive Dis-eases And Sciences2007,52,3:1
20Clinical significance of elevated alpha-fetoprotein(AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma 显示文摘Hu KQ Kyulo NL Lim N 2004Am J Gastroenterol2004,99,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费